Fluvoxamine alleviates ER stress via induction of sigma-1 receptor.

Omi, T, Tanimukai, H, Kanayama, D, Sakagami, Y, Tagami, S, Okochi, M, Morihara, T, Sato, M +9 more·2014·Cell Death & Disease
DOI 10.1038/cddis.2014.301

Cited by (113)

Items 101–113 of 113

  1. Mitochondrial Aspects of Neuronal Pathology in Triple-Transgenic Alzheimer’s Disease Mice
    John Z. Cavendish · 2019
  2. The pharmacological suppression of spreading depolarization in ischemic neuroprotection
    Írisz Szabó · 2020
  3. Sigma-1 receptor mediálta protektív mechanizmus vizsgálata TNBS-indukálta patkány colitis modellben
    Nikoletta Almási · 2021
  4. Chemo brain: myth or clinical reality? Literature review and clinical case
    Kausar K. Yakhin, Dina T. Zagretdinova, Konstantin S. Sergienko · 2024 · Neurology Bulletin
  5. The relevance of endoplasmic reticulum lumen and Anoctamin-8 for major depression: Results from a systems biology study
    Sofia Cid de Azevedo, Jacson Gabriel Feiten, Marcelo P. Fleck, Marco Antônio Caldieraro · 2025 · Journal of Psychiatric Research
  6. Additional file 1 of N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk
    Dan Cheng, Lei, Zhuo-Gui, Kin Chu, Lam, Oi Jin Honey, Chiang, Chun Yuan, Zhang, Zhang-Jin · 2024 · Figshare
  7. Additional file 1 of Utility of sustainable ratio derivative spectrophotometry for the concurrent assay of synergistic repurposed drugs for COVID-19 infections; Insilico pharmacokinetics proof
    Sara I. Aboras, Ahmed A. Megahed, Fawzy A. El‐Yazbi, Hadir Mohamed Maher · 2024 · Figshare
  8. UHPLC-MS-Based Analysis of Fluvoxamine in Rabbit Aqueous Humour and Serum: Method Development and Validation
    Andrea Guba, Anna Takácsi-Nagy, Sourav Das, Bálint Szokol, Timea Medveczki, Márton Vajna, Gergő Kalló, Andrea Fekete, Judit Hodrea, Éva Csősz · 2026 · Pharmaceuticals
  9. The evolution of SSRI research: trajectories of knowledge domains across four decades
    Lukas Westphal, Débora Dalmas Gräf, Christine E. Hallgreen · 2026 · BMC Psychiatry
  10. Fluvoxamine and lycopene alleviate cisplatin-induced kidney fibrosis by modulating miR-21 and fibrotic signaling pathways
    Sally El-Sayed Abu-Risha, Samia Salem Sokar, Mai A. Mousa, Nagla A. El‐Shitany, Alaa E. El‐Sisi · 2026 · Scientific Reports
  11. Repurposing Selective Serotonin Reuptake Inhibitors as Immunomodulators: Effects on Macrophage Activation and Polarization
    Majd H. Aldweik, Esra Aydemir, Furkan Ayaz · 2026 · Molecular Neurobiology
  12. Sigma-1 Receptor Mitigates Poly-GR-Associated Redox Dysregulation by Restoring NRF2/HO1 Signaling in C9orf72-Associated ALS
    Chao-Yi Tsai, Hsuan‐Cheng Wu, Tsung‐Ping Su, Eddie Feng‐Ju Weng, Shao‐Ming Wang · 2026 · NeuroMolecular Medicine
  13. Interplay between endoplasmic reticulum stress and mitochondrial dysfunction in inflammatory bowel disease: From molecular mechanisms to therapeutic opportunities
    Shuangshuang Li, Tongyou Zou, Jiaxuan Tian, Yanjun Li, Yinglong He, Shunhua Zhou, Haibin Wu, Meiyan Zeng, Houpan Song · 2026 · Pharmacological Research